WO2006017044A3 - Topical antiviral formulations - Google Patents
Topical antiviral formulations Download PDFInfo
- Publication number
- WO2006017044A3 WO2006017044A3 PCT/US2005/023492 US2005023492W WO2006017044A3 WO 2006017044 A3 WO2006017044 A3 WO 2006017044A3 US 2005023492 W US2005023492 W US 2005023492W WO 2006017044 A3 WO2006017044 A3 WO 2006017044A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- formulations
- topical antiviral
- antiviral formulations
- topical
- nrtis
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F6/00—Contraceptive devices; Pessaries; Applicators therefor
- A61F6/02—Contraceptive devices; Pessaries; Applicators therefor for use by males
- A61F6/04—Condoms, sheaths or the like, e.g. combined with devices protecting against contagion
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Abstract
Priority Applications (26)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020077002108A KR101225707B1 (en) | 2004-07-09 | 2005-07-01 | Topical antiviral formulations |
PL05771562T PL1773296T3 (en) | 2004-07-09 | 2005-07-01 | Pharmaceutical vaginal gel comprising tenofovir |
CN2005800232101A CN1984640B (en) | 2004-07-09 | 2005-07-01 | Topical antiviral formulations |
BRPI0513196-0A BRPI0513196A (en) | 2004-07-09 | 2005-07-01 | antiviral topical formulations |
US11/631,876 US20080035155A1 (en) | 2004-07-09 | 2005-07-01 | Topical Antiviral Formulations |
JP2007520399A JP5121451B2 (en) | 2004-07-09 | 2005-07-01 | Topical antimicrobial prescription |
AP2007003873A AP2666A (en) | 2004-07-09 | 2005-07-01 | Topical antiviral formulations |
MX2007000122A MX2007000122A (en) | 2004-07-09 | 2005-07-01 | Topical antiviral formulations. |
CA2570877A CA2570877C (en) | 2004-07-09 | 2005-07-01 | Topical antiviral formulations |
NZ552172A NZ552172A (en) | 2004-07-09 | 2005-07-01 | Topical antiviral formulations comprising [2-(6-amino-purin-9-yl)-1-methyl-ethoxymethyl]-phosphonic acid diisopropoxycarbonyloxymethyl ester (tenofovir) |
EP05771562A EP1773296B1 (en) | 2004-07-09 | 2005-07-01 | Pharmaceutical vaginal gel comprising tenofovir |
AU2005272032A AU2005272032B2 (en) | 2004-07-09 | 2005-07-01 | Topical antiviral formulations |
DE602005017497T DE602005017497D1 (en) | 2004-07-09 | 2005-07-01 | PHARMACEUTICAL VAGINAL GEL WITH TENOFOVIR |
RSP-2010/0030A RS51213B (en) | 2004-07-09 | 2005-07-01 | Pharmacetical vaginal gel comprising tenofovir |
EA200700311A EA017763B1 (en) | 2004-07-09 | 2005-07-01 | Pharmaceutical vaginal gel |
DK05771562.5T DK1773296T3 (en) | 2004-07-09 | 2005-07-01 | Pharmaceutical vaginal gel containing tenofovir |
AT05771562T ATE447396T1 (en) | 2004-07-09 | 2005-07-01 | PHARMACEUTICAL VAGINAL GEL WITH TENOFOVIR |
IL180172A IL180172A (en) | 2004-07-09 | 2006-12-19 | Pharmaceutical vaginal gel comprising tenofovir |
IS8584A IS8584A (en) | 2004-07-09 | 2006-12-21 | Topical preparations for virus protection |
HR20070040A HRP20070040A2 (en) | 2004-07-09 | 2007-02-07 | Topical antiviral formulations |
NO20070762A NO20070762L (en) | 2004-07-09 | 2007-02-08 | Topical antiviral preparations |
HK07111247.1A HK1103026A1 (en) | 2004-07-09 | 2007-10-18 | Pharmaceutical vaginal gel comprising tenofovir |
HR20100038T HRP20100038T1 (en) | 2004-07-09 | 2010-01-21 | Pharmaceutical vaginal gel comprising tenofovir |
IL206031A IL206031A0 (en) | 2004-07-09 | 2010-05-27 | Topical antiviral formulations |
US12/893,516 US9060933B2 (en) | 2004-07-09 | 2010-09-29 | Topical antiviral formulations |
US14/715,519 US20150366795A1 (en) | 2004-07-09 | 2015-05-18 | Topical antiviral formulations |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US58683904P | 2004-07-09 | 2004-07-09 | |
US60/586,839 | 2004-07-09 |
Related Child Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/631,876 A-371-Of-International US20080035155A1 (en) | 2004-07-09 | 2005-07-01 | Topical Antiviral Formulations |
US12/893,516 Continuation US9060933B2 (en) | 2004-07-09 | 2010-09-29 | Topical antiviral formulations |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2006017044A2 WO2006017044A2 (en) | 2006-02-16 |
WO2006017044A3 true WO2006017044A3 (en) | 2006-07-27 |
Family
ID=35839705
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2005/023492 WO2006017044A2 (en) | 2004-07-09 | 2005-07-01 | Topical antiviral formulations |
Country Status (31)
Country | Link |
---|---|
US (5) | US20080035155A1 (en) |
EP (4) | EP2138163A3 (en) |
JP (2) | JP5121451B2 (en) |
KR (1) | KR101225707B1 (en) |
CN (1) | CN1984640B (en) |
AP (1) | AP2666A (en) |
AR (1) | AR050424A1 (en) |
AT (1) | ATE447396T1 (en) |
AU (1) | AU2005272032B2 (en) |
BR (1) | BRPI0513196A (en) |
CA (1) | CA2570877C (en) |
CY (1) | CY1109757T1 (en) |
DE (1) | DE602005017497D1 (en) |
DK (1) | DK1773296T3 (en) |
EA (2) | EA201370001A1 (en) |
ES (1) | ES2336017T3 (en) |
HK (1) | HK1103026A1 (en) |
HR (2) | HRP20070040A2 (en) |
IL (2) | IL180172A (en) |
IS (1) | IS8584A (en) |
MX (1) | MX2007000122A (en) |
NO (1) | NO20070762L (en) |
NZ (1) | NZ552172A (en) |
PL (2) | PL382306A1 (en) |
PT (1) | PT1773296E (en) |
RS (1) | RS51213B (en) |
SI (1) | SI1773296T1 (en) |
TW (1) | TW200612955A (en) |
UA (1) | UA93354C2 (en) |
WO (1) | WO2006017044A2 (en) |
ZA (1) | ZA200700932B (en) |
Families Citing this family (59)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8512718B2 (en) | 2000-07-03 | 2013-08-20 | Foamix Ltd. | Pharmaceutical composition for topical application |
IL152486A0 (en) | 2002-10-25 | 2003-05-29 | Meir Eini | Alcohol-free cosmetic and pharmaceutical foam carrier |
US9211259B2 (en) | 2002-11-29 | 2015-12-15 | Foamix Pharmaceuticals Ltd. | Antibiotic kit and composition and uses thereof |
US8486376B2 (en) | 2002-10-25 | 2013-07-16 | Foamix Ltd. | Moisturizing foam containing lanolin |
US8119150B2 (en) | 2002-10-25 | 2012-02-21 | Foamix Ltd. | Non-flammable insecticide composition and uses thereof |
US7820145B2 (en) * | 2003-08-04 | 2010-10-26 | Foamix Ltd. | Oleaginous pharmaceutical and cosmetic foam |
US20080138296A1 (en) | 2002-10-25 | 2008-06-12 | Foamix Ltd. | Foam prepared from nanoemulsions and uses |
US9265725B2 (en) | 2002-10-25 | 2016-02-23 | Foamix Pharmaceuticals Ltd. | Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof |
US8119109B2 (en) * | 2002-10-25 | 2012-02-21 | Foamix Ltd. | Foamable compositions, kits and methods for hyperhidrosis |
US9668972B2 (en) | 2002-10-25 | 2017-06-06 | Foamix Pharmaceuticals Ltd. | Nonsteroidal immunomodulating kit and composition and uses thereof |
US7704518B2 (en) | 2003-08-04 | 2010-04-27 | Foamix, Ltd. | Foamable vehicle and pharmaceutical compositions thereof |
US20060018937A1 (en) * | 2002-10-25 | 2006-01-26 | Foamix Ltd. | Steroid kit and foamable composition and uses thereof |
US10117812B2 (en) | 2002-10-25 | 2018-11-06 | Foamix Pharmaceuticals Ltd. | Foamable composition combining a polar solvent and a hydrophobic carrier |
EP1556009B2 (en) | 2002-10-25 | 2021-07-21 | Foamix Pharmaceuticals Ltd. | Cosmetic and pharmaceutical foam |
US8900554B2 (en) | 2002-10-25 | 2014-12-02 | Foamix Pharmaceuticals Ltd. | Foamable composition and uses thereof |
US7700076B2 (en) | 2002-10-25 | 2010-04-20 | Foamix, Ltd. | Penetrating pharmaceutical foam |
US20060233721A1 (en) * | 2002-10-25 | 2006-10-19 | Foamix Ltd. | Foam containing unique oil globules |
US20080317679A1 (en) * | 2002-10-25 | 2008-12-25 | Foamix Ltd. | Foamable compositions and kits comprising one or more of a channel agent, a cholinergic agent, a nitric oxide donor, and related agents and their uses |
US7575739B2 (en) | 2003-04-28 | 2009-08-18 | Foamix Ltd. | Foamable iodine composition |
US8795693B2 (en) | 2003-08-04 | 2014-08-05 | Foamix Ltd. | Compositions with modulating agents |
US8486374B2 (en) | 2003-08-04 | 2013-07-16 | Foamix Ltd. | Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses |
UA93354C2 (en) * | 2004-07-09 | 2011-02-10 | Гилиад Сайенсиз, Инк. | Topical antiviral formulations |
CA2610662A1 (en) * | 2005-05-09 | 2007-05-18 | Foamix Ltd. | Foamable vehicle and pharmaceutical compositions thereof |
US20080152596A1 (en) * | 2005-07-19 | 2008-06-26 | Foamix Ltd. | Polypropylene glycol foamable vehicle and pharmaceutical compositions thereof |
US20080260655A1 (en) * | 2006-11-14 | 2008-10-23 | Dov Tamarkin | Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses |
WO2009007785A2 (en) * | 2006-11-14 | 2009-01-15 | Foamix Ltd. | Stable non-alcoholic foamable pharmaceutical emulsion compositions with an unctuous emollient and their uses |
US20080292560A1 (en) * | 2007-01-12 | 2008-11-27 | Dov Tamarkin | Silicone in glycol pharmaceutical and cosmetic compositions with accommodating agent |
US8636982B2 (en) | 2007-08-07 | 2014-01-28 | Foamix Ltd. | Wax foamable vehicle and pharmaceutical compositions thereof |
US9439857B2 (en) | 2007-11-30 | 2016-09-13 | Foamix Pharmaceuticals Ltd. | Foam containing benzoyl peroxide |
WO2010041141A2 (en) | 2008-10-07 | 2010-04-15 | Foamix Ltd. | Oil-based foamable carriers and formulations |
WO2009072007A2 (en) | 2007-12-07 | 2009-06-11 | Foamix Ltd. | Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof |
CA2712120A1 (en) | 2008-01-14 | 2009-07-23 | Foamix Ltd. | Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses |
CN101977610B (en) * | 2008-01-25 | 2012-05-16 | 奇默里克斯公司 | Methods of treating viral infections |
WO2009111218A2 (en) * | 2008-02-29 | 2009-09-11 | Schering Corporation | Ccr5 antagonists as prophylactics for preventing hiv infection and methods of inhibiting transmission of same |
CA2760186C (en) | 2009-04-28 | 2019-10-29 | Foamix Ltd. | Foamable vehicle and pharmaceutical compositions comprising aprotic polar solvents and uses thereof |
WO2011013008A2 (en) | 2009-07-29 | 2011-02-03 | Foamix Ltd. | Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses |
WO2011013009A2 (en) | 2009-07-29 | 2011-02-03 | Foamix Ltd. | Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses |
US8871184B2 (en) | 2009-10-02 | 2014-10-28 | Foamix Ltd. | Topical tetracycline compositions |
US9849142B2 (en) | 2009-10-02 | 2017-12-26 | Foamix Pharmaceuticals Ltd. | Methods for accelerated return of skin integrity and for the treatment of impetigo |
PT2534150T (en) | 2010-02-12 | 2017-05-02 | Chimerix Inc | Methods of treating viral infection |
WO2011139709A2 (en) | 2010-04-26 | 2011-11-10 | Chimerix, Inc. | Methods of treating retroviral infections and related dosage regimes |
EP2389929A1 (en) * | 2010-05-30 | 2011-11-30 | Abdi Ibrahim Ilac Sanayi ve Ticaret Anonim Sirketi | Pharmaceutical formulations of tenofovir |
JP5864560B2 (en) * | 2010-06-11 | 2016-02-17 | ギリアード サイエンシーズ, インコーポレイテッド | Topical antiviral formulation to prevent transmission of HSV-2 |
CA2839790A1 (en) | 2011-05-02 | 2012-11-08 | Aptalis Pharmatech, Inc. | Rapid dissolve tablet compositions for vaginal administration |
WO2013095684A1 (en) | 2011-12-22 | 2013-06-27 | Geron Corporation | Guanine analogs as telomerase substrates and telomere length affectors |
JP6352907B2 (en) * | 2012-06-13 | 2018-07-04 | イボフェム, インコーポレイテッド | Compositions and methods for enhancing the effectiveness of contraceptive fungicides |
CN102786549B (en) * | 2012-08-13 | 2013-07-03 | 洛阳聚慧投资股份有限公司 | Tenofovir diester compounds with activity of inhibiting HIV-1 (human immunodeficiency virus-1) virus replication and preparation method and pharmaceutical use thereof |
CN103665043B (en) | 2012-08-30 | 2017-11-10 | 江苏豪森药业集团有限公司 | A kind of tenofovir prodrug and its application in medicine |
EP2968109A2 (en) * | 2012-09-14 | 2016-01-20 | Cipla Limited | Topical pharmaceutical composition comprising tenofovir, an antibacterial agent and, optonally ciclopirox |
BR112015021947A2 (en) * | 2013-03-15 | 2017-07-18 | Conrad | Low glycerin formulations for HIV treatment and prevention |
ES2790703T3 (en) | 2013-12-19 | 2020-10-28 | Evofem Inc | Compositions and methods for inhibiting inflammation and disease using an antimicrobial compound based on alginic acid |
CA2972259A1 (en) | 2014-12-26 | 2016-06-30 | Emory University | N4-hydroxycytidine and derivatives and anti-viral uses related thereto |
MX2020012139A (en) | 2016-09-08 | 2021-01-29 | Vyne Pharmaceuticals Inc | Compositions and methods for treating rosacea and acne. |
CN110225750A (en) | 2016-10-04 | 2019-09-10 | 伊沃菲姆股份有限公司 | The treatment and prevention method of bacterial vaginosis BV |
BR112020010581A2 (en) | 2017-12-07 | 2020-11-10 | Emory University | pharmaceutical composition, pressurized container, and, methods to treat or prevent a viral infection and to treat or prevent human coronavirus, sars, coronavirus mers, eastern equine encephalitis virus, western equine encephalitis virus, Venezuelan equine encephalitis virus, chikungunya virus and infection by ross river infection, orthomyxoviridae virus or paramyxoviridae virus or rsv virus, or infection by influenza a virus and influenza b virus or filoviridae virus or ebola virus. |
CN108096206A (en) * | 2018-02-01 | 2018-06-01 | 海南天煌制药有限公司 | A kind of tenofovir disoproxil fumarate tablet and preparation method thereof |
EP3870167A4 (en) * | 2018-10-23 | 2022-07-27 | Eastern Virginia Medical School | Pharmaceutical compositions and methods of making on demand solid dosage formulations |
US20220372171A1 (en) * | 2019-09-20 | 2022-11-24 | Abbott Rapid Diagnostics International Unlimited Company | Antibody directed against tenofovir and derivatives thereof |
CN112891323B (en) * | 2020-01-22 | 2023-08-18 | 首都医科大学附属北京地坛医院 | anti-HIV external disinfectant and preparation method thereof |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000016755A2 (en) * | 1998-09-18 | 2000-03-30 | Glaxo Group Limited | Antiviral combinations of lamivudine and adefovir |
EP1243590A2 (en) * | 1997-07-25 | 2002-09-25 | Gilead Sciences, Inc. | Nucleotide analog composition and synthesis method |
Family Cites Families (72)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2149240A (en) | 1938-05-19 | 1939-02-28 | Calco Chemical Co Inc | Vaginal preparation |
US2330846A (en) | 1939-05-01 | 1943-10-05 | Ortho Products Inc | Spermicide |
US2467884A (en) * | 1944-02-02 | 1949-04-19 | Nathaniel M Elias | Spermicides |
US2436184A (en) | 1945-11-08 | 1948-02-17 | Eaton Lab Inc | Pharmaceutical jelly |
NL72081C (en) * | 1946-06-21 | |||
US2541103A (en) | 1948-04-27 | 1951-02-13 | Ortho Pharma Corp | Spermicidal composition |
US2623841A (en) | 1950-11-21 | 1952-12-30 | Schmid Inc Julius | Spermicidal compositions |
US2623839A (en) | 1950-11-21 | 1952-12-30 | Schmid Inc Julius | Spermicidal compositions |
US3062715A (en) | 1953-11-18 | 1962-11-06 | George S Pfaus | Vaginal tablet |
US3067743A (en) | 1958-11-12 | 1962-12-11 | Alginate Ind Ltd | Alginic compounds |
US3108043A (en) | 1960-05-09 | 1963-10-22 | Ortho Pharma Corp | Spermicidal sheet-like material |
US3174900A (en) | 1962-10-10 | 1965-03-23 | Holland Rantos Company Inc | Thioether spermicidal method and composition |
US3244589A (en) | 1962-10-26 | 1966-04-05 | Sunnen | Alkyl phenoxy polyethoxy ether spermicidal aerosol |
US3916898A (en) | 1964-05-20 | 1975-11-04 | Searle & Co | Administration of medicaments and the like |
US3887699A (en) | 1969-03-24 | 1975-06-03 | Seymour Yolles | Biodegradable polymeric article for dispensing drugs |
US3640741A (en) * | 1970-02-24 | 1972-02-08 | Hollister Inc | Composition containing gel |
FR2097520A5 (en) | 1970-07-09 | 1972-03-03 | Morel Paul | |
US3888975A (en) | 1972-12-27 | 1975-06-10 | Alza Corp | Erodible intrauterine device |
US4017730A (en) * | 1974-05-01 | 1977-04-12 | Raytheon Company | Radiographic imaging system for high energy radiation |
US4017641A (en) * | 1975-01-31 | 1977-04-12 | The Procter & Gamble Company | Skin moisturizing compositions containing 2-pyrrolidinone |
US3989816A (en) | 1975-06-19 | 1976-11-02 | Nelson Research & Development Company | Vehicle composition containing 1-substituted azacycloheptan-2-ones |
US4011312A (en) * | 1975-06-25 | 1977-03-08 | American Home Products Corporation | Prolonged release drug form for the treatment of bovine mastitis |
IT1039699B (en) | 1975-07-03 | 1979-12-10 | Prephar | SPERMICIDE COMPOSITION BASED ON BENZISOTHIAZOLIC DERIVATIVES |
US4130667A (en) | 1976-01-12 | 1978-12-19 | The Procter & Gamble Company | Dermatological compositions |
US4108309A (en) | 1976-10-15 | 1978-08-22 | All One God Faith, Inc. | Contraceptive containing device |
FR2433949A1 (en) | 1978-08-25 | 1980-03-21 | Commissariat Energie Atomique | HYDROPHOBIC SUBSTRATE CAPABLE OF RELEASING A CHEMICAL SUBSTANCE |
US4321277A (en) | 1978-12-04 | 1982-03-23 | Research Lab Products, Inc. | Germicidal use of compositions containing certain quaternary ammonium compounds |
US4187286A (en) | 1979-01-02 | 1980-02-05 | G&W Laboratories, Inc. | Contraceptive suppository |
US4954487A (en) | 1979-01-08 | 1990-09-04 | The Procter & Gamble Company | Penetrating topical pharmaceutical compositions |
US4306013A (en) | 1980-03-10 | 1981-12-15 | Rca Corporation | Asymmetrical radiation exposure of spin coated photoresist to obtain uniform thickness coating used to replicate spiral grooves in plastic substrate |
US4360013A (en) | 1980-04-21 | 1982-11-23 | Minnesota Mining And Manufacturing Company | Polymeric acid contraceptive devices |
IT1131833B (en) | 1980-06-20 | 1986-06-25 | Crinos Industria Farmaco | EXCIPIENTS FOR SPERMICIDE SUBSTANCES |
US4389330A (en) | 1980-10-06 | 1983-06-21 | Stolle Research And Development Corporation | Microencapsulation process |
US4368186A (en) | 1981-05-07 | 1983-01-11 | Syntex (U.S.A.) Inc. | Methods and compositions for intravaginal contraception |
US4415585A (en) | 1982-03-11 | 1983-11-15 | University Of Illinois Foundation | Contraceptive method |
US5248700A (en) | 1982-05-14 | 1993-09-28 | Akzo Nv | Active agent containing solid structures for prolonged release of active agents |
US4961931A (en) | 1982-07-29 | 1990-10-09 | Alza Corporation | Method for the management of hyperplasia |
US4499154A (en) | 1982-09-03 | 1985-02-12 | Howard L. Podell | Dipped rubber article |
US4551148A (en) | 1982-09-07 | 1985-11-05 | Kv Pharmaceutical Company | Vaginal delivery systems and their methods of preparation and use |
US4816570A (en) | 1982-11-30 | 1989-03-28 | The Board Of Regents Of The University Of Texas System | Biologically reversible phosphate and phosphonate protective groups |
US4557934A (en) | 1983-06-21 | 1985-12-10 | The Procter & Gamble Company | Penetrating topical pharmaceutical compositions containing 1-dodecyl-azacycloheptan-2-one |
US4552872A (en) | 1983-06-21 | 1985-11-12 | The Procter & Gamble Company | Penetrating topical pharmaceutical compositions containing corticosteroids |
US4537776A (en) | 1983-06-21 | 1985-08-27 | The Procter & Gamble Company | Penetrating topical pharmaceutical compositions containing N-(2-hydroxyethyl) pyrrolidone |
US4589880A (en) | 1983-07-14 | 1986-05-20 | Southern Research Institute | Disposable spermicide-releasing diaphragm |
US5231112A (en) | 1984-04-12 | 1993-07-27 | The Liposome Company, Inc. | Compositions containing tris salt of cholesterol hemisuccinate and antifungal |
CS263951B1 (en) | 1985-04-25 | 1989-05-12 | Antonin Holy | 9-(phosponylmethoxyalkyl)adenines and method of their preparation |
US4895724A (en) | 1985-06-07 | 1990-01-23 | Pfizer Inc. | Chitosan compositions for controlled and prolonged release of macromolecules |
US4968788A (en) | 1986-04-04 | 1990-11-06 | Board Of Regents, The University Of Texas System | Biologically reversible phosphate and phosphonate protective gruops |
US4795642A (en) | 1986-05-01 | 1989-01-03 | Pharmacaps, Inc. | Gelatin-encapsulated controlled-release composition |
US4808176A (en) | 1986-12-31 | 1989-02-28 | Kimberly-Clark Corporation | Elasticized waist integration member for disposable absorbent garments |
IE66830B1 (en) * | 1987-08-12 | 1996-02-07 | Hem Res Inc | Topically active compositions of double-stranded RNAs |
US5015474A (en) | 1988-11-22 | 1991-05-14 | Parnell Pharmaceuticals, Inc. | Composition for imparting moisture to a substrate |
US5208031A (en) | 1989-06-06 | 1993-05-04 | Kelly Patrick D | Sexual lubricants containing zinc as an anti-viral agent |
JP3347723B2 (en) | 1990-06-13 | 2002-11-20 | グラツィエル,アーノルド | Phosphorus-containing prodrug |
US5143731A (en) | 1990-08-07 | 1992-09-01 | Mediventures Incorporated | Body cavity drug delivery with thermo-irreversible polyoxyalkylene and ionic polysaccharide gels |
DE10399025I2 (en) | 1990-09-14 | 2007-11-08 | Acad Of Science Czech Republic | Active substance precursors of phosphonates |
GB9021061D0 (en) | 1990-09-27 | 1990-11-07 | Unilever Plc | Encapsulating method and products containing encapsulated material |
GB9104740D0 (en) * | 1991-03-06 | 1991-04-17 | Wellcome Found | Antiviral nucleoside combination |
GB9110624D0 (en) * | 1991-05-16 | 1991-07-03 | Glaxo Group Ltd | Combinations |
US6057305A (en) | 1992-08-05 | 2000-05-02 | Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic | Antiretroviral enantiomeric nucleotide analogs |
US6200557B1 (en) * | 1993-07-06 | 2001-03-13 | Perry A. Ratcliff | Method of treating HIV by a topical composition |
GR940100370A (en) * | 1993-07-28 | 1994-07-26 | Johnson & Johnson Consumer Products Inc. | A spermicidal anti-viral lubricant composition and method of using same. |
US5798340A (en) * | 1993-09-17 | 1998-08-25 | Gilead Sciences, Inc. | Nucleotide analogs |
US6028115A (en) | 1995-10-13 | 2000-02-22 | Rush-Presbyterian-St. Luke's Medical Center | Method for preventing sexually transmitted diseases |
US5733788A (en) | 1996-07-26 | 1998-03-31 | Gilead Sciences, Inc. | PMPA preparation |
JP4173202B2 (en) * | 1997-07-25 | 2008-10-29 | ギリアード サイエンシーズ,インコーポレイテッド | Nucleotide analog compositions and synthesis methods |
US6312662B1 (en) | 1998-03-06 | 2001-11-06 | Metabasis Therapeutics, Inc. | Prodrugs phosphorus-containing compounds |
US20020136757A1 (en) | 2000-01-28 | 2002-09-26 | Samuel Baron | Methods and devices for preventing transmission of sexually transmitted diseases |
US6899890B2 (en) * | 2002-03-20 | 2005-05-31 | Kv Pharmaceutical Company | Bioadhesive drug delivery system |
WO2003082193A2 (en) * | 2002-03-26 | 2003-10-09 | Eastern Virginia Medical School | Suramin and derivatives thereof as topical microbicide and contraceptive |
AR039540A1 (en) * | 2002-05-13 | 2005-02-23 | Tibotec Pharm Ltd | MICROBICIDE COMPOUNDS WITH PIRIMIDINE OR TRIAZINE CONTENT |
UA93354C2 (en) * | 2004-07-09 | 2011-02-10 | Гилиад Сайенсиз, Инк. | Topical antiviral formulations |
-
2005
- 2005-01-07 UA UAA200701335A patent/UA93354C2/en unknown
- 2005-07-01 RS RSP-2010/0030A patent/RS51213B/en unknown
- 2005-07-01 PL PL382306A patent/PL382306A1/en unknown
- 2005-07-01 SI SI200530903T patent/SI1773296T1/en unknown
- 2005-07-01 EA EA201370001A patent/EA201370001A1/en unknown
- 2005-07-01 EP EP09173071A patent/EP2138163A3/en not_active Withdrawn
- 2005-07-01 DE DE602005017497T patent/DE602005017497D1/en active Active
- 2005-07-01 EA EA200700311A patent/EA017763B1/en not_active IP Right Cessation
- 2005-07-01 EP EP09173070A patent/EP2138162A3/en not_active Withdrawn
- 2005-07-01 US US11/631,876 patent/US20080035155A1/en not_active Abandoned
- 2005-07-01 NZ NZ552172A patent/NZ552172A/en not_active IP Right Cessation
- 2005-07-01 EP EP05771562A patent/EP1773296B1/en active Active
- 2005-07-01 PL PL05771562T patent/PL1773296T3/en unknown
- 2005-07-01 CN CN2005800232101A patent/CN1984640B/en not_active Expired - Fee Related
- 2005-07-01 BR BRPI0513196-0A patent/BRPI0513196A/en not_active IP Right Cessation
- 2005-07-01 JP JP2007520399A patent/JP5121451B2/en not_active Expired - Fee Related
- 2005-07-01 PT PT05771562T patent/PT1773296E/en unknown
- 2005-07-01 EP EP10182466A patent/EP2283812A3/en not_active Withdrawn
- 2005-07-01 WO PCT/US2005/023492 patent/WO2006017044A2/en active Application Filing
- 2005-07-01 AP AP2007003873A patent/AP2666A/en active
- 2005-07-01 CA CA2570877A patent/CA2570877C/en not_active Expired - Fee Related
- 2005-07-01 AU AU2005272032A patent/AU2005272032B2/en not_active Ceased
- 2005-07-01 MX MX2007000122A patent/MX2007000122A/en active IP Right Grant
- 2005-07-01 KR KR1020077002108A patent/KR101225707B1/en not_active IP Right Cessation
- 2005-07-01 US US11/174,215 patent/US20060058265A1/en not_active Abandoned
- 2005-07-01 AT AT05771562T patent/ATE447396T1/en active
- 2005-07-01 ES ES05771562T patent/ES2336017T3/en active Active
- 2005-07-01 DK DK05771562.5T patent/DK1773296T3/en active
- 2005-07-06 TW TW094122885A patent/TW200612955A/en unknown
- 2005-07-08 AR ARP050102837A patent/AR050424A1/en not_active Application Discontinuation
-
2006
- 2006-12-19 IL IL180172A patent/IL180172A/en not_active IP Right Cessation
- 2006-12-21 IS IS8584A patent/IS8584A/en unknown
-
2007
- 2007-02-01 ZA ZA200700932A patent/ZA200700932B/en unknown
- 2007-02-07 HR HR20070040A patent/HRP20070040A2/en not_active Application Discontinuation
- 2007-02-08 NO NO20070762A patent/NO20070762L/en not_active Application Discontinuation
- 2007-10-18 HK HK07111247.1A patent/HK1103026A1/en not_active IP Right Cessation
-
2010
- 2010-01-21 HR HR20100038T patent/HRP20100038T1/en unknown
- 2010-01-27 CY CY20101100083T patent/CY1109757T1/en unknown
- 2010-05-27 IL IL206031A patent/IL206031A0/en unknown
- 2010-09-24 US US12/890,337 patent/US9283182B2/en active Active
- 2010-09-29 US US12/893,516 patent/US9060933B2/en active Active
-
2012
- 2012-08-24 JP JP2012185587A patent/JP2012255021A/en active Pending
-
2015
- 2015-05-18 US US14/715,519 patent/US20150366795A1/en not_active Abandoned
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1243590A2 (en) * | 1997-07-25 | 2002-09-25 | Gilead Sciences, Inc. | Nucleotide analog composition and synthesis method |
WO2000016755A2 (en) * | 1998-09-18 | 2000-03-30 | Glaxo Group Limited | Antiviral combinations of lamivudine and adefovir |
Non-Patent Citations (5)
Title |
---|
CUNDY K C ET AL: "Oral bioavailability of the antiretroviral agent 9-(2-phosphonylmethoxyethyl)adenine (PMEA) from three formulations of the prodrug bis(pivaloyloxymethyl)-PMEA in fasted male cynomolgus monkeys", PHARMACEUTICAL RESEARCH, NEW YORK, NY, US, vol. 11, no. 6, June 1994 (1994-06-01), pages 839 - 843, XP002083429, ISSN: 0724-8741 * |
KARARLI TUGRUL T ET AL: "Enhancement of transdermal transport of azidothymidine (AZT) with novel terpene and terpene-like enhancers: In vivo-in vitro correlations", JOURNAL OF CONTROLLED RELEASE, vol. 34, no. 1, 1995, pages 43 - 51, XP004037522, ISSN: 0168-3659 * |
PAUWELS RUDI ET AL: "Development of vaginal microbicides for the prevention of heterosexual transmission of HIV", JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, vol. 11, no. 3, 1996, pages 211 - 221, XP008065006, ISSN: 1077-9450 * |
TURPIN J A: "CONSIDERATIONS AND DEVELOPMENT OF TOPICAL MICROBICIDES TO INHIBIT THE SEXUAL TRANSMISSION OF HIV", EXPERT OPINION ON INVESTIGATIONAL DRUGS, ASHLEY PUBLICATIONS LTD., LONDON, GB, vol. 11, no. 8, 2002, pages 1077 - 1097, XP001105064, ISSN: 1354-3784 * |
VAN ROMPAY KOEN K A ET AL: "Topical administration of low-dose tenofovir disoproxil fumarate to protect infant macaques against multiple oral exposures of low doses of simian immunodeficiency virus.", THE JOURNAL OF INFECTIOUS DISEASES. 15 NOV 2002, vol. 186, no. 10, 15 November 2002 (2002-11-15), pages 1508 - 1513, XP002383957, ISSN: 0022-1899 * |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2006017044A3 (en) | Topical antiviral formulations | |
WO2008033851A3 (en) | Use of 2-6- (3-amino-piperidin-l-yl) -3-methyl-2, 4-dioxo-3, 4-dihydr0-2h-pyrimidin-1-ylmet hyl-4-fluoro-benzonitrile | |
NL300729I2 (en) | ||
WO2003072757A3 (en) | Nucleotide mimics and their prodrugs | |
MA31305B1 (en) | WEEKLY ADMINISTRATION OF DIPEPTIDYL PEPTIDASE INHIBITORS | |
IL193725A0 (en) | Hiv inhibiting 5-(hydroxymethylene and aminomethylene) substituted pyrimidines | |
WO2007068934A3 (en) | Pharmaceutical combination comprising nucleotide and nucleoside reverse transcriptase inhibitors (such as tenofovir and lamivudine) in different parts of the dosage unit | |
TW200744602A (en) | Administration of dipeptidyl peptidase inhibitors | |
WO2007130783A3 (en) | Metabolically stable alkoxyalkyl esters of antiviral or antiproliferative phosphonates, nucleoside phosphonates and nucleoside phosphates | |
WO2004074266A8 (en) | Hiv inhibiting 1,2,4-triazines | |
WO2006114065A3 (en) | Use of compounds to inhibit neoplasia | |
WO2003073989A3 (en) | Nucleoside 5'-monophosphate mimics and their prodrugs | |
ZA200706306B (en) | Diketo acids with nucleobase scaffolds: anti-HIV replication inhibitors targeted at HIV integrase | |
WO2010068708A3 (en) | 3'-azido purine nucleotide prodrugs for treatment of viral infections | |
WO2005123049A3 (en) | A pharmaceutical composition for increasing the mitochondrial genesis | |
WO2007042571A8 (en) | Novel pyrimidine-2,4-diamine derivatives and their use as modulators of small-conductance calcium-activated potassium channels | |
WO2008118879A3 (en) | Antiviral compositions comprising 2 compounds | |
WO2006129056A3 (en) | Process and novel salt | |
WO2007138462A3 (en) | Aqueous oral formulations of risperidone | |
WO2006086865A3 (en) | Combi-preparation of nucleoside and non-nucleoside reverse transcriptase inhibitors for the treatment of hiv infections | |
WO2005105062A3 (en) | 2-methylthiazolidine-2,4-dicarboxylic acid-containing combination preparations | |
TH76514A (en) | Topical antiviral formula | |
UA99112C2 (en) | Use of 2-[6-(3-amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydr0-2h-pyrimidin-1-ylmethyl]-4-fluorobenzonitrile |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU LV MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DPE1 | Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2570877 Country of ref document: CA Ref document number: 1200602055 Country of ref document: VN |
|
WWE | Wipo information: entry into national phase |
Ref document number: 552172 Country of ref document: NZ Ref document number: 180172 Country of ref document: IL Ref document number: 2007520399 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 7840/DELNP/2006 Country of ref document: IN |
|
WWE | Wipo information: entry into national phase |
Ref document number: AP/P/2007/003873 Country of ref document: AP Ref document number: 2005272032 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 382306 Country of ref document: PL Ref document number: MX/a/2007/000122 Country of ref document: MX |
|
WWE | Wipo information: entry into national phase |
Ref document number: 200580023210.1 Country of ref document: CN |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1020077002108 Country of ref document: KR |
|
ENP | Entry into the national phase |
Ref document number: 2005272032 Country of ref document: AU Date of ref document: 20050701 Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2005771562 Country of ref document: EP Ref document number: 2007/00932 Country of ref document: ZA Ref document number: 200700932 Country of ref document: ZA |
|
WWP | Wipo information: published in national office |
Ref document number: 2005272032 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: P20070040A Country of ref document: HR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 200700311 Country of ref document: EA |
|
WWP | Wipo information: published in national office |
Ref document number: 2005771562 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 11631876 Country of ref document: US |
|
ENP | Entry into the national phase |
Ref document number: PI0513196 Country of ref document: BR |
|
WWE | Wipo information: entry into national phase |
Ref document number: P-2010/0030 Country of ref document: RS |
|
WWE | Wipo information: entry into national phase |
Ref document number: 206031 Country of ref document: IL |